NYSE:EVHC - Envision Healthcare Stock Price, Price Target & More

$37.41 -0.57 (-1.50 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$37.41
Today's Range$37.17 - $38.05
52-Week Range$23.77 - $64.00
Volume2.56 million shs
Average Volume2.25 million shs
Market Capitalization$4.59 billion
P/E Ratio15.08
Dividend YieldN/A
Beta0.42

About Envision Healthcare (NYSE:EVHC)

Envision Healthcare logoEnvision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services. The company also offers ambulatory surgical centers (ASCs) services that provide surgical procedures across multiple specialties, including gastroenterology, ophthalmology, orthopedics, and others. It operated 264 ASCs in 35 states and the District of Columbia. In addition, it provides surgery services, such as management, oversight, and surgeon staffing for trauma surgery services; offers direct patient care and care coordination by clinicians outside the acute care setting through physician-led post-acute care services; and operates office-based medical practices that primarily focus on women's health, as well as provides physician staffing and related management services. Further, it offers medical transportation services in 41 states and the District of Columbia. The company offers its clinical solutions for health systems, payors, providers, and patients. Envision Healthcare Corporation was founded in 1992 and is based in Nashville, Tennessee.

Receive EVHC News and Ratings via Email

Sign-up to receive the latest news and ratings for EVHC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
SymbolNYSE:EVHC
CUSIPN/A
Phone615-665-1283

Debt

Debt-to-Equity Ratio0.87%
Current Ratio3.40%
Quick Ratio3.38%

Price-To-Earnings

Trailing P/E Ratio15.08
Forward P/E Ratio11.20
P/E Growth0.88

Sales & Book Value

Annual Sales$12.18 billion
Price / Sales0.37
Cash Flow$6.1127 per share
Price / Cash6.12
Book Value$59.24 per share
Price / Book0.63

Profitability

EPS (Most Recent Fiscal Year)$2.48
Net Income$-228,000,000.00
Net Margins-2.52%
Return on Equity4.62%
Return on Assets1.90%

Miscellaneous

Employees69,300
Outstanding Shares120,930,000

How to Become a New Pot Stock Millionaire

Envision Healthcare (NYSE:EVHC) Frequently Asked Questions

What is Envision Healthcare's stock symbol?

Envision Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVHC."

How will Envision Healthcare's stock buyback program work?

Envision Healthcare announced that its board has initiated a share repurchase plan on Tuesday, September 19th 2017, which authorizes the company to repurchase $250,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 4.5% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board of directors believes its shares are undervalued.

How were Envision Healthcare's earnings last quarter?

Envision Healthcare (NYSE:EVHC) announced its quarterly earnings data on Tuesday, February, 27th. The company reported $0.59 EPS for the quarter, topping the consensus estimate of $0.45 by $0.14. The business earned $2 billion during the quarter, compared to the consensus estimate of $1.97 billion. Envision Healthcare had a positive return on equity of 4.62% and a negative net margin of 2.52%. The company's quarterly revenue was up 68.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.15 EPS. View Envision Healthcare's Earnings History.

When is Envision Healthcare's next earnings date?

Envision Healthcare is scheduled to release their next quarterly earnings announcement on Monday, May, 7th 2018. View Earnings Estimates for Envision Healthcare.

What guidance has Envision Healthcare issued on next quarter's earnings?

Envision Healthcare issued an update on its FY18 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of $3.46 to $3.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.31. The company issued revenue guidance of $8.35 billion to $8.53 billion, compared to the consensus revenue estimate of $8.30 billion.Envision Healthcare also updated its Q1 guidance to $0.61 to $0.67 EPS.

What price target have analysts set for EVHC?

14 Wall Street analysts have issued 1-year price objectives for Envision Healthcare's stock. Their predictions range from $31.00 to $50.00. On average, they expect Envision Healthcare's share price to reach $40.6071 in the next twelve months. View Analyst Ratings for Envision Healthcare.

What are Wall Street analysts saying about Envision Healthcare stock?

Here are some recent quotes from research analysts about Envision Healthcare stock:
  • 1. Canaccord Genuity analysts commented, "We reiterate our BUY rating and raise our PT to $46 based on an improving financial outlook given restructuring and easing utilization headwinds. The company characterized guidance as highly visible and not heroic. As such, we recommend continued exposure as utilization headwinds dissipate and the operational improvement plan takes hold. Key positive: High visibility into 2018 guidance: The low-end of 2018 adj-EBITDA of $960M is 87% in hand when annualizing 4Q’17. M&A from 2017 and 2018 should contribute an incremental $10-$15M and $20-$30M, respectively, bringing visibility up to 92% coverage at the low-end. Organic growth and further expense benefits from operational improvements would be the last leg in getting to guidance. Key negative: Consolidated organic growth rate lowered to 2-5% (was 3-6%) taking into account a softer utilization environment." (2/28/2018)
  • 2. Cantor Fitzgerald analysts commented, "Revised 2018 estimates. We are lowering our 2018 adjusted EPS estimate to $3.75 from $3.95 and bringing down our adjusted 2018 EBITDA estimate to $950.6 million from $982 million to account for slightly higher seasonality, primarily in terms of salary, wages and benefits, which account for the majority of EVHC’s operating expenses. Our new estimate is just below the $960 million midpoint of management’s potential 2018 performance, as outlined in a presentation last November, but it remains above the $925.1 million FactSet consensus." (2/21/2018)
  • 3. According to Zacks Investment Research, "Envision Healthcare's stock has outperformed the industry in last one month. The company has taken some discrete actions which are expected to improve its operating performance and realize $50 million of incremental adjusted EBITDA in 2018. It is optimistic about the physician services market, which is witnessing consolidation. Also the divestiture of its AMR business will help the company to focus on its core operations. The company is aggressively shifting its payor contract to in-network from out of network which will lead to greater client and patient satisfaction, competitive differentiation, administrative efficiency, enhanced collections and an accelerated cash flow. But, it suffers from high indebtedness, consequently leading to an increase in the interest ratio. Also, its operating expense is on the rise and is exceeding the revenue growth to have exerted pressure on the operating margins." (1/2/2018)

Are investors shorting Envision Healthcare?

Envision Healthcare saw a increase in short interest in the month of March. As of March 29th, there was short interest totalling 24,458,190 shares, an increase of 12.8% from the March 15th total of 21,681,282 shares. Based on an average daily volume of 2,365,494 shares, the days-to-cover ratio is currently 10.3 days. Currently, 20.7% of the shares of the company are short sold.

Who are some of Envision Healthcare's key competitors?

Who are Envision Healthcare's key executives?

Envision Healthcare's management team includes the folowing people:
  • Mr. William A. Sanger, Exec. Chairman (Age 68)
  • Mr. Christopher A. Holden, CEO, Pres & Director (Age 54)
  • Ms. Claire M. Gulmi, Advisor (Age 64)
  • Mr. Kevin D. Eastridge, Exec. VP & CFO (Age 53)
  • Mr. Karey Lynn Witty, Exec. VP & COO (Age 53)

Has Envision Healthcare been receiving favorable news coverage?

Media stories about EVHC stock have trended somewhat positive on Saturday, Accern reports. The research group identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Envision Healthcare earned a media sentiment score of 0.14 on Accern's scale. They also assigned media stories about the company an impact score of 45.98 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of Envision Healthcare?

Shares of EVHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Envision Healthcare's stock price today?

One share of EVHC stock can currently be purchased for approximately $37.41.

How big of a company is Envision Healthcare?

Envision Healthcare has a market capitalization of $4.59 billion and generates $12.18 billion in revenue each year. The company earns $-228,000,000.00 in net income (profit) each year or $2.48 on an earnings per share basis. Envision Healthcare employs 69,300 workers across the globe.

How can I contact Envision Healthcare?

Envision Healthcare's mailing address is 1A BURTON HILLS BOULEVARD, NASHVILLE TN, 37215. The company can be reached via phone at 615-665-1283 or via email at [email protected]


MarketBeat Community Rating for Envision Healthcare (EVHC)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  468 (Vote Outperform)
Underperform Votes:  243 (Vote Underperform)
Total Votes:  711
MarketBeat's community ratings are surveys of what our community members think about Envision Healthcare and other stocks. Vote "Outperform" if you believe EVHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVHC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Envision Healthcare (NYSE:EVHC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
14 Wall Street analysts have issued ratings and price targets for Envision Healthcare in the last 12 months. Their average twelve-month price target is $40.6071, suggesting that the stock has a possible upside of 8.55%. The high price target for EVHC is $50.00 and the low price target for EVHC is $31.00. There are currently 6 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.572.572.603.00
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
12 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $40.6071$40.6071$38.6429$73.30
Price Target Upside: 8.55% upside3.04% upside10.66% upside76.84% upside

Envision Healthcare (NYSE:EVHC) Consensus Price Target History

Price Target History for Envision Healthcare (NYSE:EVHC)

Envision Healthcare (NYSE:EVHC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/11/2018Robert W. BairdSet Price TargetBuy$50.00HighView Rating Details
4/11/2018Jefferies GroupSet Price TargetBuy$46.00HighView Rating Details
3/2/2018MizuhoSet Price TargetHold$38.00LowView Rating Details
3/1/2018Royal Bank of CanadaReiterated RatingBuy$48.00LowView Rating Details
3/1/2018SunTrust BanksBoost Price TargetPositive -> Buy$45.00LowView Rating Details
2/28/2018Canaccord GenuityReiterated RatingBuy -> Buy$32.00 -> $46.00HighView Rating Details
2/28/2018Cantor FitzgeraldBoost Price TargetNeutral -> Neutral$37.00 -> $40.00HighView Rating Details
1/31/2018Credit Suisse GroupBoost Price TargetOutperform -> Positive$36.00 -> $43.50LowView Rating Details
1/10/2018StephensReiterated RatingHold$34.00LowView Rating Details
12/13/2017Piper JaffrayInitiated CoverageNeutral -> Neutral$35.00LowView Rating Details
11/14/2017KeyCorpSet Price TargetBuy$40.00N/AView Rating Details
11/2/2017OppenheimerLower Price TargetOutperform$77.00 -> $40.00N/AView Rating Details
11/2/2017CitigroupDowngradeBuy -> Neutral$31.00N/AView Rating Details
11/2/2017Bank of AmericaDowngradeBuy -> Neutral$32.00N/AView Rating Details
3/21/2017BarclaysReiterated RatingOverweightLowView Rating Details
12/29/2016Raymond JamesReiterated RatingStrong-Buy$100.00 -> $90.00N/AView Rating Details
12/9/2016Goldman SachsInitiated CoverageBuyN/AView Rating Details
12/7/2016UBSUpgradeMarket Perform -> OutperformN/AView Rating Details
11/2/2016Wells FargoUpgradeMarket Perform -> OutperformN/AView Rating Details
5/8/2016Morgan StanleyReiterated RatingHoldN/AView Rating Details
(Data available from 4/21/2016 forward)

Earnings

Envision Healthcare (NYSE:EVHC) Earnings History and Estimates Chart

Earnings by Quarter for Envision Healthcare (NYSE:EVHC)

Envision Healthcare (NYSE:EVHC) Earnings Estimates

2018 EPS Consensus Estimate: $3.08
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.51$0.62$0.57
Q2 20182$0.72$0.75$0.74
Q3 20182$0.78$0.88$0.83
Q4 20182$0.94$0.96$0.95

Envision Healthcare (NYSE EVHC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/7/2018$0.57N/AView Earnings Details
2/27/2018Q4 2017$0.45$0.59$1.9724 billion$2.0030 billionViewN/AView Earnings Details
10/31/2017Q3 2017$0.81$0.73$2.0337 billion$1.99 billionViewN/AView Earnings Details
8/7/2017Q2 2017$0.75$0.79$1.9551 billion$1.9470 billionViewListenView Earnings Details
5/2/2017Q1 2017$0.69$0.69$2.5231 billion$1.8786 billionViewListenView Earnings Details
2/28/2017Q416$1.20$1.08$1.41 billion$1.3906 billionViewListenView Earnings Details
11/1/2016Q316$0.36$0.36$1.67 billion$1.64 billionViewN/AView Earnings Details
8/2/2016Q216$0.36$0.34$1.66 billion$1.6410 billionViewN/AView Earnings Details
5/3/2016Q1$0.25$0.28$1.55 billion$1.5975 billionViewN/AView Earnings Details
2/24/2016Q415$0.35$0.35$1.45 billion$1.4818 billionViewListenView Earnings Details
11/3/2015Q3 2015$0.91$0.99$643.74 million$650.23 millionViewN/AView Earnings Details
10/22/2015Q315$0.39$0.30$1.41 billion$1.37 billionViewListenView Earnings Details
8/4/2015Q215$0.35$0.37$1.30 billion$1.35 billionViewListenView Earnings Details
5/5/2015Q115$0.26$0.26$1.19 billion$1.24 billionViewN/AView Earnings Details
2/25/2015Q414$0.36$0.36$1.16 billion$1.16 billionViewN/AView Earnings Details
11/4/2014Q314$0.33$0.35$1.13 billion$1.1503 billionViewN/AView Earnings Details
7/31/2014Q214$0.25$0.28$1.04 billion$1.0753 billionViewN/AView Earnings Details
4/22/2014Q114$0.19$0.20$1.02 billion$1.0140 billionViewN/AView Earnings Details
3/5/2014Q413$0.17$0.20$994.41 million$984.80 millionViewN/AView Earnings Details
2/25/2014Q4 2013$0.57$0.60$282.97 million$284.57 millionViewN/AView Earnings Details
11/13/2013Q3 13$0.13$0.13$950.22 million$955.90 millionViewN/AView Earnings Details
10/22/2013Q3 2013$0.53$0.53$265.62 million$268.23 millionViewN/AView Earnings Details
7/23/2013Q2 2013$0.55$0.58$266.01 million$269.34 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.52$0.52$261.36 million$260.06 millionViewN/AView Earnings Details
2/25/2013Q4 2012$0.51$0.49ViewN/AView Earnings Details
10/23/2012Q3 2012$0.49$0.49ViewN/AView Earnings Details
7/24/2012Q2 2012$0.50$0.51ViewN/AView Earnings Details
4/24/2012Q1 2012$0.48$0.50ViewN/AView Earnings Details
2/23/2012Q4 2011$0.46$0.46ViewN/AView Earnings Details
10/25/2011Q3 2011$0.44$0.46ViewN/AView Earnings Details
7/21/2011Q2 2011$0.41$0.41ViewN/AView Earnings Details
4/21/2011Q1 2011$0.38$0.38ViewN/AView Earnings Details
2/24/2011Q4 2010$0.42$0.43ViewN/AView Earnings Details
10/21/2010Q3 2010$0.42$0.43ViewN/AView Earnings Details
7/22/2010Q2 2010$0.42$0.43ViewN/AView Earnings Details
4/22/2010Q1 2010$0.42$0.42ViewN/AView Earnings Details
2/24/2010Q4 2009$0.42$0.42ViewN/AView Earnings Details
10/22/2009Q3 2009$0.43$0.44ViewN/AView Earnings Details
7/23/2009Q2 2009$0.41$0.45ViewN/AView Earnings Details
4/23/2009Q1 2009$0.39$0.40ViewN/AView Earnings Details
2/19/2009Q4 2008$0.40$0.40ViewN/AView Earnings Details
10/23/2008Q3 2008$0.38$0.39ViewN/AView Earnings Details
7/22/2008Q2 2008$0.39$0.39ViewN/AView Earnings Details
4/22/2008Q1 2008$0.37$0.37ViewN/AView Earnings Details
2/19/2008Q4 2007$0.37$0.37ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Envision Healthcare (NYSE:EVHC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Envision Healthcare (NYSE EVHC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.10%
Insider Trading History for Envision Healthcare (NYSE:EVHC)
Institutional Ownership by Quarter for Envision Healthcare (NYSE:EVHC)

Envision Healthcare (NYSE EVHC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/3/2017Robert Jon CowardInsiderSell1,500$62.69$94,035.0097,863View SEC Filing  
6/22/2017Robert Jon CowardInsiderSell1,500$60.00$90,000.0099,363View SEC Filing  
5/3/2017Robert Jon CowardInsiderSell1,500$60.53$90,795.00114,363View SEC Filing  
4/3/2017Robert Jon CowardInsiderSell1,500$61.34$92,010.00115,863View SEC Filing  
3/10/2017John Thomas GawaluckDirectorBuy1,500$66.65$99,975.006,080View SEC Filing  
3/1/2017Robert Jon CowardInsiderSell1,500$65.00$97,500.00104,319View SEC Filing  
10/5/2015Leonard M Riggs JrDirectorSell4,000$36.24$144,960.0032,179View SEC Filing  
9/15/2015Randel G OwenCFOSell20,000$42.00$840,000.00367,683View SEC Filing  
9/14/2015William A. SangerCEOSell175,000$41.06$7,185,500.00View SEC Filing  
8/17/2015Randel G OwenCFOSell140,000$44.22$6,190,800.00View SEC Filing  
8/17/2015Todd G ZimmermanCEOSell180,000$44.21$7,957,800.00View SEC Filing  
7/6/2015Leonard M Riggs JrDirectorSell4,000$39.32$157,280.00View SEC Filing  
6/25/2015Dighton PackardInsiderSell40,000$40.00$1,600,000.00View SEC Filing  
4/20/2015Dighton PackardInsiderSell240,188$39.44$9,473,014.72View SEC Filing  
4/16/2015Horne Edward VanInsiderSell10,000$40.00$400,000.00View SEC Filing  
4/16/2015William A SangerCEOSell418,500$40.00$16,740,000.00View SEC Filing  
4/13/2015Craig A WilsonSVPSell18,600$39.57$736,002.00View SEC Filing  
4/13/2015Leonard M Riggs JrDirectorSell4,000$39.57$158,280.00View SEC Filing  
3/19/2015Horne Edward VanInsiderSell12,000$38.00$456,000.00View SEC Filing  
3/19/2015Randel G OwenCFOSell50,000$38.04$1,902,000.00View SEC Filing  
3/16/2015Richard J SchnallDirectorBuy100,000$36.73$3,673,000.00View SEC Filing  
3/9/2015Steven G MurphySVPSell12,021$36.03$433,116.63View SEC Filing  
2/25/2015William A SangerCEOSell153,782$37.50$5,766,825.00View SEC Filing  
2/23/2015William A SangerCEOSell7,100$37.54$266,534.00View SEC Filing  
1/9/2015William A SangerCEOSell194,968$37.52$7,315,199.36View SEC Filing  
1/8/2015Randel G OwenCFOSell200,000$36.56$7,312,000.00View SEC Filing  
10/31/2014Randel G OwenCFOSell19,180$35.00$671,300.00View SEC Filing  
10/28/2014Randel G OwenCFOSell30,820$35.00$1,078,700.00View SEC Filing  
10/24/2014Todd G ZimmermanCEOSell125,000$35.00$4,375,000.00View SEC Filing  
10/22/2014Horne Edward VanInsiderSell6,540$35.00$228,900.00View SEC Filing  
10/6/2014Horne Edward VanInsiderSell10,200$35.00$357,000.00View SEC Filing  
10/1/2014Horne Edward VanInsiderSell10,606$34.67$367,710.02View SEC Filing  
9/29/2014Dighton PackardInsiderSell32,400$34.97$1,133,028.00View SEC Filing  
9/29/2014Michael L SmithDirectorSell7,000$34.97$244,790.00View SEC Filing  
9/29/2014Randel G OwenCFOSell150,000$34.97$5,245,500.00View SEC Filing  
9/29/2014Steve W Ratton JrEVPSell25,000$34.97$874,250.00View SEC Filing  
9/29/2014William A SangerCEOSell200,000$34.97$6,994,000.00View SEC Filing  
9/15/2014Steven G MurphySVPSell45,988$34.75$1,598,083.00View SEC Filing  
7/16/2014Horne Edward VanInsiderSell20,269$32.90$666,850.10View SEC Filing  
7/16/2014Leonard M Riggs JrDirectorSell15,000$32.90$493,500.00View SEC Filing  
7/16/2014Randel G OwenCFOSell249,375$32.90$8,204,437.50View SEC Filing  
7/16/2014Steve W Ratton JrEVPSell42,948$32.90$1,412,989.20View SEC Filing  
7/16/2014Steven G MurphySVPSell21,852$32.90$718,930.80View SEC Filing  
7/16/2014William A SangerCEOSell543,900$32.90$17,894,310.00View SEC Filing  
8/19/2013Leonard M Riggs JrDirectorBuy44,000$23.00$1,012,000.00View SEC Filing  
8/19/2013Steven G MurphySVPBuy5,000$23.00$115,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Envision Healthcare (NYSE EVHC) News Headlines

Source:
DateHeadline
Head-To-Head Comparison: Concord Medical Services (CCM) and Envision Healthcare (EVHC)Head-To-Head Comparison: Concord Medical Services (CCM) and Envision Healthcare (EVHC)
www.americanbankingnews.com - April 21 at 5:14 AM
Envision Healthcare (EVHC) Expected to Announce Earnings of $0.64 Per ShareEnvision Healthcare (EVHC) Expected to Announce Earnings of $0.64 Per Share
www.americanbankingnews.com - April 20 at 7:14 PM
Royal Bank of Canada Increases Envision Healthcare (EVHC) Price Target to $77.00Royal Bank of Canada Increases Envision Healthcare (EVHC) Price Target to $77.00
www.americanbankingnews.com - April 20 at 3:39 PM
Envision Healthcare (EVHC) Given "Buy" Rating at Cantor FitzgeraldEnvision Healthcare (EVHC) Given "Buy" Rating at Cantor Fitzgerald
www.americanbankingnews.com - April 19 at 10:46 PM
Envision Healthcare Sets Earnings Release and Conference Call Dates for First Quarter 2018 ResultsEnvision Healthcare Sets Earnings Release and Conference Call Dates for First Quarter 2018 Results
finance.yahoo.com - April 16 at 8:56 AM
Short Interest in Envision Healthcare (EVHC) Increases By 12.8%Short Interest in Envision Healthcare (EVHC) Increases By 12.8%
www.americanbankingnews.com - April 16 at 2:42 AM
Teladoc (TDOC) and Envision Healthcare (EVHC) Financial AnalysisTeladoc (TDOC) and Envision Healthcare (EVHC) Financial Analysis
www.americanbankingnews.com - April 15 at 7:21 AM
BidaskClub Downgrades Envision Healthcare (EVHC) to SellBidaskClub Downgrades Envision Healthcare (EVHC) to Sell
www.americanbankingnews.com - April 14 at 5:51 PM
Investors Purchase High Volume of Envision Healthcare Call Options (EVHC)Investors Purchase High Volume of Envision Healthcare Call Options (EVHC)
www.americanbankingnews.com - April 13 at 6:11 AM
Mattel: S&P 500’s Top Gainer on April 11Mattel: S&P 500’s Top Gainer on April 11
finance.yahoo.com - April 12 at 4:53 PM
Health insurance giant terminates contract with Nashville firm amid accusations of overchargingHealth insurance giant terminates contract with Nashville firm amid accusations of overcharging
www.bizjournals.com - April 11 at 4:51 PM
After the Bell: Dow Gains 430 Points, but Beware the Shrinking MultipleAfter the Bell: Dow Gains 430 Points, but Beware the Shrinking Multiple
finance.yahoo.com - April 11 at 9:35 AM
Envision Healthcare (EVHC) PT Set at $46.00 by Jefferies GroupEnvision Healthcare (EVHC) PT Set at $46.00 by Jefferies Group
www.americanbankingnews.com - April 11 at 9:19 AM
Envision Healthcare (EVHC) PT Set at $50.00 by Robert W. BairdEnvision Healthcare (EVHC) PT Set at $50.00 by Robert W. Baird
www.americanbankingnews.com - April 11 at 9:19 AM
Envision down 4% on UnitedHealthcare exitEnvision down 4% on UnitedHealthcare exit
seekingalpha.com - April 10 at 4:51 PM
Envision Healthcare (EVHC) and Concord Medical Services (CCM) Head-To-Head SurveyEnvision Healthcare (EVHC) and Concord Medical Services (CCM) Head-To-Head Survey
www.americanbankingnews.com - April 10 at 11:19 AM
Contrasting Envision Healthcare (EVHC) & Concord Medical Services (CCM)Contrasting Envision Healthcare (EVHC) & Concord Medical Services (CCM)
www.americanbankingnews.com - April 9 at 7:14 AM
Envision Healthcare (EVHC) Rating Reiterated by Robert W. BairdEnvision Healthcare (EVHC) Rating Reiterated by Robert W. Baird
www.americanbankingnews.com - April 6 at 11:31 PM
Envision Healthcare (EVHC) vs. iKang Healthcare Group (KANG) Critical SurveyEnvision Healthcare (EVHC) vs. iKang Healthcare Group (KANG) Critical Survey
www.americanbankingnews.com - April 6 at 9:47 AM
 Analysts Anticipate Envision Healthcare (EVHC) Will Post Quarterly Sales of $2.02 Billion Analysts Anticipate Envision Healthcare (EVHC) Will Post Quarterly Sales of $2.02 Billion
www.americanbankingnews.com - April 5 at 2:16 AM
Is Envision Healthcare Corporation’s (NYSE:EVHC) PE Ratio A Signal To Buy For Investors?Is Envision Healthcare Corporation’s (NYSE:EVHC) PE Ratio A Signal To Buy For Investors?
finance.yahoo.com - April 4 at 9:08 AM
Envision Healthcare (EVHC) Receives Consensus Rating of "Hold" from AnalystsEnvision Healthcare (EVHC) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - April 4 at 3:24 AM
ValuEngine Lowers Envision Healthcare (EVHC) to SellValuEngine Lowers Envision Healthcare (EVHC) to Sell
www.americanbankingnews.com - April 3 at 4:16 PM
Envision Healthcare (EVHC) Given a $71.00 Price Target at Jefferies GroupEnvision Healthcare (EVHC) Given a $71.00 Price Target at Jefferies Group
www.americanbankingnews.com - April 2 at 3:42 PM
Envision Healthcare (EVHC) Cut to "Equal Weight" at StephensEnvision Healthcare (EVHC) Cut to "Equal Weight" at Stephens
www.americanbankingnews.com - April 2 at 8:21 AM
Envision Healthcare (EVHC) Downgraded to "Neutral" at Bank of AmericaEnvision Healthcare (EVHC) Downgraded to "Neutral" at Bank of America
www.americanbankingnews.com - April 2 at 7:59 AM
Envision Healthcare (EVHC) Lowered to Neutral at CitigroupEnvision Healthcare (EVHC) Lowered to Neutral at Citigroup
www.americanbankingnews.com - April 2 at 12:30 AM
KeyCorp Cuts Envision Healthcare (EVHC) Price Target to $37.00KeyCorp Cuts Envision Healthcare (EVHC) Price Target to $37.00
www.americanbankingnews.com - April 1 at 10:20 PM
Envision Healthcare (EVHC) PT Lowered to $40.00Envision Healthcare (EVHC) PT Lowered to $40.00
www.americanbankingnews.com - April 1 at 10:20 PM
Envision Healthcare Co. (EVHC) Short Interest UpdateEnvision Healthcare Co. (EVHC) Short Interest Update
www.americanbankingnews.com - April 1 at 2:50 AM
Envision Healthcare (EVHC) Stock Rating Lowered by ValuEngineEnvision Healthcare (EVHC) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - March 31 at 2:06 PM
Envision Healthcare (EVHC) Upgraded by Zacks Investment Research to "Hold"Envision Healthcare (EVHC) Upgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - March 31 at 1:12 PM
Why Is Envision Healthcare Corporation (EVHC) Up 4.57% Since Its Last Earnings Report?Why Is Envision Healthcare Corporation (EVHC) Up 4.57% Since Its Last Earnings Report?
www.zacks.com - March 29 at 4:50 PM
Envision Healthcare (EVHC) Lowered to Hold at ValuEngineEnvision Healthcare (EVHC) Lowered to Hold at ValuEngine
www.americanbankingnews.com - March 25 at 6:25 PM
Is Envision Healthcare (EVHC) a Great Stock for Value Investors?Is Envision Healthcare (EVHC) a Great Stock for Value Investors?
finance.yahoo.com - March 21 at 5:02 PM
$0.64 EPS Expected for Envision Healthcare Co. (EVHC) This Quarter$0.64 EPS Expected for Envision Healthcare Co. (EVHC) This Quarter
www.americanbankingnews.com - March 17 at 5:12 PM
Envision Healthcare (EVHC) Given a $46.00 Price Target at Jefferies GroupEnvision Healthcare (EVHC) Given a $46.00 Price Target at Jefferies Group
www.americanbankingnews.com - March 17 at 3:28 PM
[$$] Deal Close Announcements: March 12-16[$$] Deal Close Announcements: March 12-16
finance.yahoo.com - March 16 at 5:49 PM
Envision Healthcare Divests AMR Unit, Streamlines BusinessEnvision Healthcare Divests AMR Unit, Streamlines Business
finance.yahoo.com - March 16 at 9:12 AM
With An ROE Of 6.33%, Has Envision Healthcare Corporation’s (NYSE:EVHC) Management Done Well?With An ROE Of 6.33%, Has Envision Healthcare Corporation’s (NYSE:EVHC) Management Done Well?
finance.yahoo.com - March 14 at 6:13 PM
Why J.C. Penney, China Lodging Group, and Envision Healthcare Slumped TodayWhy J.C. Penney, China Lodging Group, and Envision Healthcare Slumped Today
finance.yahoo.com - March 14 at 6:13 PM
Envision Healthcare Completes Divestiture of American Medical ResponseEnvision Healthcare Completes Divestiture of American Medical Response
finance.yahoo.com - March 14 at 6:13 PM
Why BioScrip (BIOS) Could Be Positioned for a SlumpWhy BioScrip (BIOS) Could Be Positioned for a Slump
www.msn.com - March 14 at 9:49 AM
Envision Healthcare Co. (EVHC) Given Average Rating of "Hold" by BrokeragesEnvision Healthcare Co. (EVHC) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - March 10 at 3:54 AM
Envision Healthcare Target of Unusually Large Options Trading (EVHC)Envision Healthcare Target of Unusually Large Options Trading (EVHC)
www.americanbankingnews.com - March 8 at 7:51 AM
UnitedHealth Joins Bids for Envision UnitUnitedHealth Joins Bids for Envision Unit
finance.yahoo.com - March 6 at 5:06 PM
University of Notre Dame DU Lac Increases Position in Envision Healthcare Co. (EVHC)University of Notre Dame DU Lac Increases Position in Envision Healthcare Co. (EVHC)
www.americanbankingnews.com - March 6 at 10:02 AM
Envision Healthcare Co. (EVHC) Holdings Raised by Rhumbline AdvisersEnvision Healthcare Co. (EVHC) Holdings Raised by Rhumbline Advisers
www.americanbankingnews.com - March 6 at 9:02 AM
Silchester International Investors LLP Takes $1.48 Million Position in Envision Healthcare Co. (EVHC)Silchester International Investors LLP Takes $1.48 Million Position in Envision Healthcare Co. (EVHC)
www.americanbankingnews.com - March 5 at 2:27 PM
Envision Healthcare Co. Forecasted to Earn Q3 2018 Earnings of $0.88 Per Share (EVHC)Envision Healthcare Co. Forecasted to Earn Q3 2018 Earnings of $0.88 Per Share (EVHC)
www.americanbankingnews.com - March 5 at 4:13 AM

SEC Filings

Envision Healthcare (NYSE:EVHC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Envision Healthcare (NYSE:EVHC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Envision Healthcare (NYSE EVHC) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.